Results 91 to 100 of about 2,146 (159)

Ravulizumab in IgA Nephropathy

Journal of the American Society of Nephrology
Gao, Youyuan, Huang, Yunjian
openaire   +4 more sources

Efficacy of Ravulizumab During the Acute Phase of Neuromyelitis Optica Spectrum Disorder. [PDF]

Case Rep Neurol Med
Tsuzaki K, Mitsui G, Inagaki Y, Uehara N, Wada S, Hamano T.   +5 more
europepmc   +1 more source

Breakthrough serogroup Y meningococcal disease in a vaccinated patient with myasthenia gravis receiving ravulizumab: a case report. [PDF]

BMC Infect Dis
Strugar SŠ, Petrović P, Butić I, Gjurašin B, Kutleša M.   +4 more
europepmc   +1 more source

Meningococcemia in a Boy with Dense Deposit Disease Receiving the C5 Complement Inhibitor Ravulizumab: A Case Report. [PDF]

Clin Pract Cases Emerg Med
Gonedes AJ, Martinez A, Greissman AM, Atia H, Boccio E.   +4 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry. [PDF]

Am J Hematol
Röth A, Patriquin CJ, Szer J, Terriou L, Patel AS, Metzger J, Gustovic P, Nishimura JI, Brodsky RA.   +8 more
europepmc   +1 more source

Research Progress in Pharmacological Targeted Therapy for Myasthenia Gravis. [PDF]

J Inflamm Res
Zhou Y, Wu Y, Meng Z.
europepmc   +1 more source

Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature review. [PDF]

Ther Adv Neurol Disord
Gan KX, Abu Hassan SHB, Tan XL, Li KZ, Thirugnanam U, Yeo T.   +5 more
europepmc   +1 more source

Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan. [PDF]

Neurol Ther
Chihara N, Lee J, Yu JC, Numajiri N, Misu T.   +4 more
europepmc   +1 more source

Efficacy and Safety of Treatments for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review. [PDF]

J Clin Med
Gandhi S, Munro I, Shodimu V, Webb N, Pannagl K, Wiyani A, Balp MM.   +6 more
europepmc   +1 more source

Clinical similarity in cost-comparison evaluations: a systematic review of current methods in NICE appraisals and the development of a framework for the formal assessment of clinical similarity. [PDF]

BMJ Open
Edwards SJ, Burgess BJ, Downes N, Ip S, Walters A, Dadswell C.   +5 more
europepmc   +1 more source